Surgery Partners Inc Revenue Growth Rates (SGRY), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Surgery Partners Inc   (NASDAQ: SGRY)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

SGRY's Revenue Growth by Quarter and Year

Surgery Partners Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SGRY Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 848.90
1st Quarter March 810.90
FY 1,659.80

SGRYs Annual Revenue
Surgery Partners Inc 's Revenue in the fiscal year 2025 $ 3,308.70 millions
Surgery Partners Inc 's Revenue in the fiscal year 2024 $ 3,114.30 millions
Surgery Partners Inc 's Revenue in the fiscal year 2023 $ 2,743.30 millions
Surgery Partners Inc 's Revenue in the fiscal year 2022 $ 2,539.30 millions
Surgery Partners Inc 's Revenue in the fiscal year 2021 $ 2,225.10 millions




SGRY Revenue second quarter 2026 Y/Y Growth Comment
Surgery Partners Inc reported Revenue growth of 2.75% year on year in the second quarter 2026, to $ 848.90 millions, this is lower than Surgery Partners Inc 's recent average Revenue improvement of 27.27%.

Looking into second quarter 2026 results within Healthcare Facilities industry 25 other companies have achieved higher Revenue growth. While Surgery Partners Inc ' s Revenue increase of 2.75% ranks overall at the positon no. 2493 in the second quarter 2026.


SGRY Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 2.38 % 17.54 % 4 %
3rd Quarter September - 6.63 % 14.29 % 8.62 %
2nd Quarter June 2.75 % 8.41 % 14.16 % 8.48 %
1st Quarter March 4.5 % 8.17 % 7.69 % 11.74 %
FY   - 6.24 % 13.52 % -

Financial Statements
Surgery Partners Inc 's second quarter 2026 Revenue $ 848.90 millions SGRY's Income Statement
Surgery Partners Inc 's second quarter 2025 Revenue $ 826.20 millions Quarterly SGRY's Income Statement


SGRY Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 7.73 % 12.2 % 9.09 %
3rd Quarter September - -0.57 % 1.09 % 0.97 %
2nd Quarter June 4.69 % 6.47 % 6.23 % 0.21 %
1st Quarter March -8.37 % -10.23 % -2.45 % -5.78 %
FY (Year on Year)   - 6.24 % 13.52 % -


Back to SGRY Growth rate Comparisons >> Back to SGRY Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #26
Healthcare Sector #358
Overall #2493

Revenue Y/Y Growth Statistics
High Average Low
218.02 % 27.27 % -15.87 %
(Sep 30 2017)   (Jun 30 2020)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #26
Healthcare Sector #358
Overall #2493
Revenue Y/Y Growth Statistics
High Average Low
218.02 % 27.27 % -15.87 %
(Sep 30 2017)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Surgery Partners Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
135.5 % 6.8 % -15.03 %
(Dec 31 2014)  


SGRY's II. Quarter Q/Q Revenue Comment
Surgery Partners Inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.69% quarter on quarter, to $ 848.90 millions.

Within Healthcare Facilities industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Surgery Partners Inc 's Revenue growth quarter on quarter, overall rank is 1116.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #167
Overall #1116
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #167
Overall #1116
Revenue Q/Q Growth Statistics
High Average Low
135.5 % 6.8 % -15.03 %
(Dec 31 2014)  


SGRY's II. Quarter Q/Q Revenue Comment
Surgery Partners Inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.69% quarter on quarter, to $ 848.90 millions.

Within Healthcare Facilities industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Surgery Partners Inc 's Revenue growth quarter on quarter, overall rank is 1116.


Surgery Partners Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 3,366.30 $ 3,343.60 $ 3,308.70 $ 3,288.10 $ 3,237.00
Y / Y Revenue Growth (TTM) 3.99 % 5.38 % 6.24 % 10.14 % 12.05 %
Year on Year Revenue Growth Overall Ranking # 1116 # 1042 # 964 # 0 # 1066
Seqeuential Revenue Change (TTM) 0.68 % 1.05 % 0.63 % 1.58 % 2.02 %
Seq. Revenue Growth (TTM) Overall Ranking # 2270 # 2158 # 1787 # 0 # 1543


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Surgery Partners Inc 's cumulative twelve months Revenue were $ 3,366 millions, company would post below average annual Revenue growth of 2.02% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Surgery Partners Inc 's Revenue growth from the 810.9% growth in Mar 31 2026.

In the Healthcare sector 212 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1042 to 1116.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 23
Healthcare Sector # 213
Overall # 1116

Revenue TTM Y/Y Growth Statistics
High Average Low
107.91 %
 19.06 %
0.76 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 332
S&P 500 # 2270
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Surgery Partners Inc 's cumulative twelve months Revenue were $ 3,366 millions, company would post below average annual Revenue growth of 0.76% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Surgery Partners Inc 's Revenue growth from the 810.9% growth in Mar 31 2026.

In the Healthcare sector 212 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1042 to 1116.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 23
Healthcare Sector # 213
Overall # 1116

Revenue TTM Y/Y Growth Statistics
High Average Low
107.91 %
19.06 %
0.76 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 332
S&P 500 # 2270




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SGRY's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Zimmer Biomet Holdings Inc 4.80%$ 4.799 millions
Mettler toledo International Inc 4.48%$ 4.485 millions
Phibro Animal Health Corporation4.40%$ 4.405 millions
Align Technology inc 4.35%$ 4.355 millions
Opko Health Inc 4.32%$ 4.319 millions
Dariohealth Corp 4.29%$ 4.291 millions
Orthofix Medical Inc 4.15%$ 4.147 millions
Pediatrix Medical Group Inc 4.04%$ 4.040 millions
Nrc Health3.98%$ 3.978 millions
Bioventus Inc 3.76%$ 3.757 millions
Heron Therapeutics Inc 3.64%$ 3.640 millions
Prime Medicine Inc 3.50%$ 3.498 millions
Inogen Inc 3.04%$ 3.042 millions
Pacific Health Care Organization Inc2.79%$ 2.786 millions
Quidelortho Corp2.77%$ 2.769 millions
C4 Therapeutics Inc 2.75%$ 2.754 millions
Surgery Partners Inc 2.75%$ 2.748 millions
Lantheus Holdings Inc 2.69%$ 2.690 millions
Healthcare Services Group Inc 2.69%$ 2.686 millions
Adma Biologics Inc 2.61%$ 2.613 millions
Pfizer Inc2.60%$ 2.600 millions
Infusystem Holdings Inc2.59%$ 2.586 millions
Outset Medical Inc 2.49%$ 2.488 millions
3m Company2.46%$ 2.459 millions
Strata Critical Medical Inc 2.41%$ 2.408 millions
Nature s Sunshine Products inc 2.35%$ 2.350 millions
Solventum Corporation2.22%$ 2.221 millions
Adc Therapeutics Sa2.17%$ 2.171 millions
Moderna Inc 2.11%$ 2.113 millions
Co diagnostics Inc 1.98%$ 1.977 millions


About Surgery Partners Inc Revenue Growth Rates (SGRY), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Surgery Partners Inc (CIK 1638833).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001638833-26-000077
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Surgery Partners Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.